Objective: To investigate the quality and complete-ness of clinical and economic data in dossiers submitted by drug companies to a health plan using Academy of Managed Care Pharmacy guidelines (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback